Dako Corp.
Country not established
- Devices
- 54
What Dako Corp. makes
Dako Corp. manufactures diagnostic reagents and kits for immunohistochemistry, including rabbit antisera (e.g., anti-human C4 and kappa light chains), monoclonal antibodies (e.g., anti-human estrogen receptor and CD markers like CD2, CD19, CD30), and staining systems for pathogens such as *Pneumocystis carinii*. Their portfolio also includes ELISA kits (e.g., rotavirus testing) and labeled streptavidin-biotin detection systems for tissue staining, as well as immunoassay reagents for immunoglobulin fraction analysis.
The company’s products are classified under FDA’s Class I and Class II regulatory categories, with many authorised via the 510(k) pathway. These devices are listed in the FDA’s 510(k) database, reflecting their compliance with U.S. medical device regulations. Dako Corp. is headquartered in the United States.
Catalogue
Search and filter all 54 devicesShowing 1-50 of 54
Frequently asked questions
How many devices does Dako Corp. have in the registry?
The registry currently lists 54 devices for Dako Corp.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Dako Corp.'s devices?
Among its 50 most recently registered devices, Dako Corp. has devices listed in FDA 510(k) (50 devices).
What risk classes do Dako Corp.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for Dako Corp.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Dako Corp. in the registry?
The most recently registered devices listed for Dako Corp. include RABBIT ANTISERUM TO HUMAN C4, DAKO PAP KIT K504, STAINING SYSTEM FOR PNEUMOCYSTIS CARINII and DAKO MONOCLONAL MOUSE ANTI-HUMAN ESTROGEN RECEPTOR.